 ?您的位置：對(duì)照品 > 標(biāo)準(zhǔn)品 > 歐洲藥典標(biāo)準(zhǔn)品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：B686580 |
| 產(chǎn)品名稱：5-(4-Bromophenyl)-3-(1,2-dihydro-6-methyl-2-oxo-4-phenyl-3-quinolinyl)-4,5-dihydro-&ga |
| 產(chǎn)品CAS：380560-89-4 |
| 規(guī)格含量：50mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
B686580 |
| 名稱: |
5-(4-Bromophenyl)-3-(1,2-dihydro-6-methyl-2-oxo-4-phenyl-3-quinolinyl)-4,5-dihydro-γ-oxo-1H-Pyrazole-1-butanoic Acid |
| 別名: |
4-(5-(4-bromophenyl)-3-(6-methyl-2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)-4,5-dihydro-1H-pyrazol-1-yl)-4-oxobutanoic Acid; DC 060015; DQP-1105; |
| CAS號(hào): |
380560-89-4 |
| 分子式: |
C??H??BrN?O? |
| 分子量: |
558.42 |
| 類別: |
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Acts as a new class of NMDA receptor antagonists with potential application in neurological disability treatment and therapy. |
| 參考文獻(xiàn) |
|
|
|
|
|
|
